Hormonal therapy for menopause and ovarian cancer in a collaborative re- analysis of European studies

International Journal of Cancer

Volumn 80, Issue 6, 1999, Pages 848-851

  Negri, Eva ^a   Tzonou, Anastasia ^b   Beral, Valerie ^c   Lagiou, Pagona ^b   Trichopoulos, Dimitrios ^b,d   Parazzini, Fabio ^a   Franceschi, Silvia ^e   Booth, Margareth ^f   La Vecchia, Carlo ^a,d,g  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN THERAPY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; META ANALYSIS; ORAL CONTRACEPTION; OVARY CARCINOMA; PARITY; PRIORITY JOURNAL; SOCIOECONOMICS;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; GREAT BRITAIN; GREECE; HORMONE REPLACEMENT THERAPY; HUMANS; ITALY; MENOPAUSE; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; PARITY; RISK; SOCIOECONOMIC FACTORS;

EID: 0033559179     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990315)80:6<848::AID-IJC8>3.0.CO;2-E     Document Type: Article

References (23)

1. BOOTH, M., BERAL, V. and SMITH, P., Risk factors for ovarian cancer: a case-control study. Brit. J. Cancer, 60, 592-598 (1989).
2. BRESLOW, N.E. and DAY, N.E., Statistical methods in cancer research. Vol. 1. The analysis of case-control study, IARC Scientific Publication 32, IARC, Lyon (1980).
3. CRAMER, D.W., HUTCHISON, G.B., WELCH, W.R., SCULLY, R.E. and KNAPP, R.C., Factors affecting the association of oral contraceptives and ovarian cancer. N. Engl. J. Med., 307, 1047-1051 (1982).
4. CRAMER, D.W. and WELCH, W.R., Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J. nat. Cancer Inst., 71, 717-721 (1983).
5. HARRIS, R., WHITTEMORE, A.S., ITNYRE, J. and THE COLLABORATIVE OVARIAN CANCER GROUP, Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Amer. J. Epidemiol., 136, 1204-1211 (1992).
6. HEMMINKI, E., KENNEDY, D.L., BAUM, C. and MCKINLAY, S.M., Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Amer. J. publ. Health, 78, 1479-1481 (1988).
7. KAUFMAN, D.W., KELLY, J.P., WELCH, W.R., ROSENBERG, L., STOLLEY, P.D., WARSHAUER, M.E., LEWIS, J., WOODRUFF, J. and SHAPIRO, S., Noncontraceptive estrogen use and epithelial ovarian cancer. Amer. J. Epidemiol., 130, 1142-1151 (1989).
8. LA VECCHIA, C., Oestrogen replacement treatment and breast cancer: update of an Italian case-control study. In: R.D. Mann (ed.), Hormone replacement therapy and breast cancer risk, pp. 107-116, Parthenon, Carnforth (1992).
9. LA VECCHIA, C., LIBERATI, A. and FRANCESCHI, S., Noncontraceptive estrogen use and the occurrence of ovarian cancer. J. nat. Cancer Inst., 69, 1207 (1982).
10. NEGRI, E., FRANCESCHI, S., TZONOU, A., BOOTH, M., LA VECCHIA, C., PARAZZINI, F., BERAL, V. BOYLE, P. and TRICHOPOULOS, D., Pooled analysis of 3 European case-control studies. I. Reproductive factors and risk of epithelial ovarian cancer. Int. J. Cancer, 49, 50-56 (1991).
11. PARAZZINI, F., FRANCESCHI, S., LA VECCHIA, C. and FASOLI, M., The epidemiology of ovarian cancer. Gynecol. Oncol. 43, 9-23 (1991).
12. PARAZZINI, F., LA VECCHIA, C. NEGRI, E., BIANCHI, C. and FEDELE, L., Determinants of estrogen replacement therapy use in northern Italy. Rev. Epidemiol. Santé Publ., 41, 53-58 (1993).
13. PARAZZINI, F., LA VECCHIA, C., NEGRI, E. and VILLA, A., Estrogen replacement therapy and ovarian cancer risk. Int. J. Cancer, 57, 135-136 (1994).
14. POLYCHRONOPOULOU, A., TZONOU, A., HSIEH, C., KAPRINIS, G., REBELAKOS, A., TOUPADAKI, N. and TRICHOPOULOS, D., Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int. J. Cancer, 55, 402-407 (1993).
15. PURDIE, D., GREEN, A., BAIN, C., SISKIND, V., WARD, B., HACKER, N., QUINN, M., WRIGHT, G., RUSSEL, P. and SUSIL, B., FOR THE SURVEY OF WOMEN'S HEALTH STUDY GROUP, Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Int. J. Cancer, 62, 678-684 (1995).
16. RISCH, H.A., Estrogen replacement therapy and risk of epithelial ovarian cancer. Gynecol. Oncol., 63, 254-257 (1996).
17. RISCH, H.A., MARRETT, L.D., JAIN, M. and HOWE, G.R., Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Amer. J. Epidemiol., 144, 363-372 (1996).
18. RODRIGUEZ, C., CALLE, E.E., COATES, R.J., MIRACLE-MCMAHILL, H.L., THUN, M.J. and HEATH, C.W., JR., Estrogen replacement therapy and fatal ovarian cancer. Amer. J. Epidemiol., 141, 828-835 (1995).
19. SIMON, W.E., ALBRECHT, M., HÄNSEL, M., DIETEL, M. and HÖLZER, F., Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J. nat. Cancer Inst., 70, 839-845 (1983).
20. TZONOU, A., DAY, N.E., TRICHOPOULOS, D., WALKER, A., SALIARAKI, M., PAPAPOSTOLOU, M. and POLYCHRONOPOULOU, A., The epidemiology of ovarian cancer in Greece: a case-control study. Europ. J. Cancer clin. Oncol., 20, 1045-1052 (1984).
21. WEISS, N.S., LYON, J.L., KRISHNAMURTHY, S., DIETERT, S.E., LIFF, J.M. and DALING, J.R., Noncontraceptive estrogen use and the occurrence of ovarian cancer. J. nat. Cancer Inst., 68, 95-98 (1982).
22. WHITTEMORE, A.S., HARRIS, R., ITNYRE, J. and THE COLLABORATIVE OVARIAN CANCER GROUP, Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Amer. J. Epidemiol., 136, 1184-1203 (1992).
23. WIDE, L., NAESSEN, T. and PHILLIPS, D.J., Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women. Clin. Endocrinol., 42, 59-64 (1995).